# Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer

> **NCT02725424** · PHASE2 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 180 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** S-1
- **DRUG:** Trastuzumab
- **DRUG:** Oxaliplatin
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT02725424
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2018-12
- **Final completion:** 2019-06
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2022-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02725424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02725424, "Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02725424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*